Next Generation Sequencing Testing (NGS)
NHS Blood and Transplant
This contract was awarded to SGS United Kingdom Limited. It runs until 12 October 2027. Contracts like this usually come back out to tender before they end.
Live now: tenders like this
- Continuous Testing (PTaaS) Service AgreementThames Water Utilities Limited£2,000,000 · Closes 10 November 2026
- In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717Supply Chain Coordination Limited£703,101,796 · Closes 16 December 2026
- Penetration TestingSenedd Cymru / Welsh Parliament£80,000 · Closes 24 November 2026
- CIE 7289 - QUALIFICATION SYSTEM FOR PROVISION OF PENETRATION TESTINGCloses 17 January 2029
- Ireland West SDZ Designated Activity Company DAC is seeking consultancy services to support the development of an Aviation Circular Economy Hub at Ireland West Airport Knock.Mayo County Council€125,000 · Closes 24 November 2026
Get tenders like this by email
New tenders like this one, in your inbox every morning. Starts with 14 days of Pro, no card needed.
Unsubscribe in one click. See our privacy policy.
Key details
Procurement
- 72225000 System quality assurance assessment and review services
What happened
NHS Blood and Transplant awarded this contract to SGS United Kingdom Limited worth £407,200 on 13 Oct 2026. The contract runs until 12 Oct 2027.
Description
NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.
Awarded supplier
Contact
Identifiers
Explore related tenders
External ID: fts-ocds-h6vhtk-0514f8 • Added 25 June 2026